The maintenance of an Outperform rating by BMO Capital indicates a positive outlook on AMN Healthcare Services, suggesting confidence in the company's fundamentals or growth prospects. However, the reduction in the price target from $80 to $71 could reflect adjustments in valuation metrics, possibly due to revised earnings expectations or market conditions. This mixed signal might lead to short-term uncertainty among investors, potentially causing minor fluctuations in the stock price. The overall impact is considered neutral in the short term as the positive rating offsets the negative price target adjustment.